Stereotactic ablative radiotherapy (SABR) using 70Gy in 10 fractions for non-small cell lung cancer: Exploration of clinical indications
- 1 August 2014
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 112 (2), 256-261
- https://doi.org/10.1016/j.radonc.2014.07.010
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Stereotactic Ablative Radiation Therapy for Centrally Located Early Stage or Isolated Parenchymal Recurrences of Non-Small Cell Lung Cancer: How to Fly in a “No Fly Zone”International Journal of Radiation Oncology*Biology*Physics, 2014
- Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): Solid evidence or “no-go”?Radiotherapy and Oncology, 2013
- Outcomes of stereotactic ablative radiotherapy for central lung tumours: A systematic reviewRadiotherapy and Oncology, 2013
- Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancerRadiation Oncology, 2012
- Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumorsRadiotherapy and Oncology, 2012
- Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung CancerJournal of Thoracic Oncology, 2011
- Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive PatientsInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJama-Journal Of The American Medical Association, 2010
- Stereotactic Body Radiation Therapy in Centrally and Superiorly Located Stage I or Isolated Recurrent Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006